Transplant Outcomes in Acute Leukemia (II)

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 51-58

  Hough, Rachael ^a   Rocha, Vanderson ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN;

ACUTE LEUKEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; DONOR SELECTION; ENGRAFTMENT; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNE RESPONSE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MORTALITY; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; T CELL DEPLETION; TREATMENT OUTCOME;

ALGORITHMS; BLOOD DONORS; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA; PATIENT SELECTION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 72449141109     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.005     Document Type: Article

References (46)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
2. Dew A., Collins D., Artz A., Rich E., Stock W., Swanson K., et al. Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. Biol Blood Marrow Transplant 14 (2008) 938-941
3. Barker J.N., Krepski T.P., DeFor T.E., Davies S.M., Wagner J.E., and Weisdorf D.J. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8 (2002) 257-260
4. Powles R.L., Morgenstern G.R., Kay H.E., McElwain T.J., Clink H.M., Dady P.J., et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1 8325 (1983) 612-615
5. Beatty P.G., Clift R.A., Mickelson E.M., Nisperos B.B., Flournoy N., Martin P.J., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313 (1985) 765-771
6. Anasetti C., and Hansen J.A. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Transfus Sci 15 (1994) 221-230
7. Peters C., Matthes-Martin S., Fritsch G., Holter W., Lion T., Witt V., et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 13 (1999) 2070-2078
8. Reisner Y., and Martelli M.F. Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 12 (2000) 536-541
9. Handgretinger R., Klingebiel T., Lang P., Schumm M., Neu S., Geiselhart A., et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27 (2001) 777-783
10. Ortin M., Raj R., Kinning E., Williams M., and Darbyshire P.J. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplant 30 (2002) 359-366
11. Henslee-Downey P.J., Abhyankar S.H., Parrish R.S., Pati A.R., Godder K.T., Neglia W.J., et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 89 (1997) 3864-3872
12. Aversa F., Terenzi A., Tabilio A., Falzetti F., Carotti A., Ballanti S., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23 (2005) 3447-3454
13. Klingebiel T., Cornish J., Labopin M., Locatelli F., Balduzzi A., and Owoc J. Risk factors for outcome after haploidentical hematopoietic stem cell transplant in children with very high risk acute lymphoblastic leukemia: impact of centre experience. A survey on behalf of the ALWP and PDWP of the EBMT [abstract 438]a. Blood 108 (2006) 134a
14. Ciceri F., Labopin M., Aversa F., Rowe J.M., Bunjes D., Lewalle P., et al. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood 112 (2008) 3574-3581
15. Klingebiel T., Lang P., Schumm M., Koehl U., Bader P., Schwabe D., et al. Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. Pathol Biol (Paris) 53 (2005) 159-161
16. Ruggeri L., Mancusi A., Capanni M., Urbani E., Carotti A., Aloisi T., et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 110 (2007) 433-440
17. Marks D.I., Khattry N., Cummins M., Goulden N., Green A., Harvey J., et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 134 (2006) 196-201
18. Lang P., Greil J., Bader P., Handgretinger R., Klingebiel T., Schumm M., et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 33 (2004) 281-287
19. Passweg J.R., Kuhne T., Gregor M., Favre G., Avoledo P., Tichelli A., et al. Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants. Bone Marrow Transplant 26 (2000) 1033-1036
20. Szydlo R., Goldman J.M., Klein J.P., Gale R.P., Ash R.C., Bach F.H., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15 (1997) 1767-1777
21. Stern M., Ruggeri L., Mancusi A., Bernardo M.E., de Angelis C., Bucher C., et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 112 (2008) 2990-2995
22. Aversa F. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States. Bone Marrow Transplant 41 (2008) 473-481
23. Lang P., Schumm M., Greil J., Bader P., Klingebiel T., Muller I., et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Paediatr 217 (2005) 334-338
24. Chen X., Hale G.A., Barfield R., Benaim E., Leung W.H., Knowles J., et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 135 (2006) 524-532
25. Handgretinger R., Chen X., Pfeiffer M., Mueller I., Feuchtinger T., Hale G.A., et al. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci 1106 (2007) 279-289
26. Dodero A., Carniti C., Raganato A., Vendramin A., Farina L., Spina F., et al. Haploidentical stem cell transplantation following a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: post-transplant CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. Blood 113 (2009) 4771-4779
27. Lang P., and Handgretinger R. Haploidentical SCT in children: an update and future perspectives. Bone Marrow Transplant 42 Suppl 2 (2008) S54-S59
28. Feuchtinger T., Richard C., Pfeiffer M., Neuhauser F., Lucke J., Handgretinger R., et al. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Paediatr 217 (2005) 339-344
29. Ball L.M., Lankester A.C., Bredius R.G., Fibbe W.E., van Tol M.J., and Egeler R.M. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 35 Suppl 1 (2005) S35-S38
30. Perruccio K., Tosti A., Burchielli E., Topini F., Ruggeri L., Carotti A., et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 106 (2005) 4397-4406
31. Comoli P., Basso S., Zecca M., Pagliara D., Baldanti F., Bernardo M.E., et al. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 7 (2007) 1648-1655
32. Feuchtinger T., Matthes-Martin S., Richard C., Lion T., Fuhrer M., Hamprecht K., et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 134 (2006) 64-76
33. Locatelli F., Comoli P., Montagna D., Rossi F., Daudt L., and Maccario R. Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 17 (2004) 479-492
34. Ball L.M., Bernardo M.E., Roelofs H., Lankester A., Cometa A., Egeler R.M., et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110 (2007) 2764-2767
35. Hough R., Labopin M., Michel G., Locatelli F., Klingebiel T., Arcese W., et al. Outcomes of fully haploidentical haematopoietic stem cell transplantation compared to unrelated cord blood transplantation in children with acute lymphoblastic leukaemia. Bone Marrow Transplant 39 Suppl 1 (2007) 1176
36. Rocha V., Aversa F., Labopin M., Sanz G., Ciceri F., Arcese W., et al. Outcomes of unrelated cord blood and haploidentical transplantation in adults with acute leukaemia [abstract 301]. Blood 106 (2005)
37. Drobyski W.R., Klein J., Flomenberg N., Pietryga D., Vesole D.H., Margolis D.A., et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 99 (2002) 806-814
38. Chen X.H., Gao L., Zhang X., Gao L., Zhang C., Kong P.Y., et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Blood Cells Mol Dis 43 (2009) 98-104
39. Eapen M., Rubinstein P., Zhang M.J., Stevens C., Kurtzberg J., Scaradavou A., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369 (2007) 1947-1954
40. Barker J.N., Davies S.M., DeFor T., Ramsay N.K., Weisdorf D.J., and Wagner J.E. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97 (2001) 2957-2961
41. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., Peters C., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
42. Dalle J.H., Duval M., Moghrabi A., Wagner E., Vachon M.F., Barrette S., et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 33 (2004) 605-611
43. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
44. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
45. Shaw B.E., Veys P., Pagliuca A., Addada J., Cook G., Craddock C.F., et al. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant 44 (2009) 7-12
46. Rocha V., and Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 41 (2008) 207-214